MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CRNX made $10,734K in revenue. -$130,964K in net income. Net profit margin of -1220.09%.

Income Overview

Revenue
$10,734K
Net Income
-$130,964K
Net Profit Margin
-1220.09%
EPS
-$1.23
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License And Service

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
10,734 6,161 143 1,031
Cost of product revenue
200 269* --
Research and development
100,081 85,053 90,464 80,301
Selling, general and administrative
50,831 54,505* 52,265 49,842
Total operating expenses
151,112 139,827 142,729 130,143
Loss from operations
-140,378 -133,666 -142,586 -129,112
Interest income
12,664 11,156 12,544 13,455
Other income (expense), net
---20
Other expense, net
-131 -125 -49 -
Total other income, net
12,533 11,031 12,495 13,475
Loss before income taxes
--122,770* -130,091 -
Income tax expense
-45* --
Loss before equity method investment
--122,815* -115,637
Loss on equity method investment
-0* 0 0
Net loss
-127,845 -122,815 -130,091 -115,637
Unrealized loss (gain) on investment securities
-3,147 -206 594 -347
Unrealized gain on foreign currency
28 -123 -21 -34
Total other comprehensive income (gain)
-3,119 -329 573 -381
Comprehensive loss
-130,964 -123,144 -129,518 -116,018
Basic EPS
-1.23 -1.295 -1.38 -1.23
Diluted EPS
-1.23 -1.295 -1.38 -1.23
Basic Average Shares
104,099,000 95,120,000 94,215,000 93,791,000
Diluted Average Shares
104,099,000 95,120,000 94,215,000 93,791,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$130,964K (-36.80%↓ Y/Y)Interest income$12,664K (-14.63%↓ Y/Y)Net loss-$127,845K (-32.11%↓ Y/Y)Total othercomprehensive income (gain)-$3,119K (-400.19%↓ Y/Y)Total other income,net$12,533K (-14.34%↓ Y/Y)Unrealized gain on foreigncurrency$28K (366.67%↑ Y/Y)Product$10,306K License And Service$428K Other expense, net-$131K (35.47%↑ Y/Y)Loss from operations-$140,378K (-26.01%↓ Y/Y)Unrealized loss (gain) oninvestment securities-$3,147K (-404.65%↓ Y/Y)Total revenue$10,734K (2873.41%↑ Y/Y)Total operatingexpenses$151,112K (35.20%↑ Y/Y)Research and development$100,081K (31.27%↑ Y/Y)Selling, general andadministrative$50,831K Cost of productrevenue$200K

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)